About Emily Whitehead Foundation

This author has not yet filled in any details.
So far Emily Whitehead Foundation has created 23 blog entries.

Celebrating 6 Years Cancer Free!

It was on this day six years ago that we learned the T-cell therapy had not only saved Emily's life, but also left no evidence of leukemia cells. She was free of cancer, and Kari and I didn’t have to find out what it would be like living without our only daughter.

T-Cell Therapy Patient Story: Colton Matter

When Colton Matter was 9 years old, an accident with a scooter revealed an unanticipated diagnosis: hypo-diploid acute lymphoblastic leukemia. Four years later, following multiple relapses and two bone marrow transplants, Colton was eligible for the CAR-T cell trial at CHOP. Colton is now more than two years cancer free!

By |2018-05-10T14:36:08+00:00November 7th, 2017|Patient Stories|0 Comments

T-Cell Therapy Patient Story: Nick Wilkins

Nick Wilkins was four years old when a routine doctor appointment led to an unwanted diagnosis: Acute Lymphoblastic Leukemia. When Nick relapsed for the second time following years of standard chemotherapy and a bone marrow transplant, he was entered into the CAR-T cell therapy clinical trial at CHOP as Patient #15. Today, Nick is healthy, attending college, and 4.5 years cancer free!

By |2018-05-29T13:29:51+00:00October 25th, 2017|Patient Stories|0 Comments

T-Cell Therapy Patient Story: Jeremiah “L.J.” Graham

Jeremiah "L.J." Graham was diagnosed with Acute Lymphoblastic Leukemia when he was five years old. Following multiple relapses, L.J.'s remaining treatment options were few. In March 2015, L.J. was accepted into the Phase I CAR-T cell clinical trial at Children's Hospital of Philadelphia (CHOP). Two and a half years later, L.J. remains cancer free!

By |2018-05-10T14:35:38+00:00October 17th, 2017|Patient Stories|0 Comments

T-Cell Therapy Patient Story: Ryan Durant

At age eleven, Ryan Durant was diagnosed with Acute Lymphoblastic Leukemia. When Ryan's cancer proved to be resistant to standard chemotherapy treatments, his doctors recommend the CAR-T cell trial at Duke University. Ryan received his T-cells in January 2016 and has since remained cancer free!

By |2018-08-03T12:57:47+00:00September 26th, 2017|Patient Stories|0 Comments